ERLOCIP 150 MG TABLET

Composition for ERLOCIP 150 MG TABLET Primary uses of : Non-small cell lung cancer, Pancreatic cancer
Manufacturer: Cipla Ltd
*
₹ 8,774.00 incl tax
Expert advice for Erlocip Tablet Erlotinib tablets should be taken either 1 hour before or 2 hours after ingestion of food.Erlotinib is not recommended for children and adolescents under 18 years of age.Stop smoking and use effective contraceptive measures while on erlotinib treatment.Do not start erlotinib if you use contact lenses, have had eye problems (ulcers in front part of eye, dry eyes, inflammation in front part of eye), liver or kidney problems, Gilbert’s syndrome (liver disorder that causes increased bilirubin), intolerance to some sugars, are pregnant or breast-feeding.Tell your doctor if you suffer from breathing difficulty associated with fever or cough, severe diarrhea, loss of appetite, nausea or vomiting, severe blistering or peeling of skin, severe pain in abdomen, acute or increasing pain and redness in eye, blurred vision or sensitivity to light, increased eye watering.
Composition Composition for ERLOCIP 150 MG TABLET
Side Effect Erlocip Tablet side effects Common Nausea, Vomiting, Fatigue, Breathing difficulty, Abdominal pain, Edema (swelling), Weight loss, Loss of appetite, Anemia (low number of red blood cells), Infection, Bone pain, Constipation, Diarrhoea, Fever, Stomatitis (Inflammation of the mouth), Rash.
How to works How Erlocip Tablet works ERLOCIP 150 MG TABLET is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.